ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RX Biosyent Inc

9.00
0.50 (5.88%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 17.92M20.76M21.53M21.42M22.33M28.62M27.93M31.59M
Operating Income 5.77M6.44M6.68M5.66M5.29M8.61M7.26M8.06M
Pre Tax Income 5.87M6.85M7.55M5.87M5.24M8.38M7.43M8.54M
Net Income 4.31M5.21M5.71M4.37M3.8M6.28M5.46M6.46M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.2990.3590.3950.3230.2960.4920.4420.532
EBIT 5.77M6.44M6.68M5.66M5.29M8.74M7.26M8.06M
EBITDA 5.91M6.69M6.93M6.82M5.8M9.07M7.71M8.52M